Cargando…
Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway
While cisplatin is a first-line chemotherapeutic drug commonly used to treat patients with oral squamous cell carcinoma (OSCC), the cisplatin-resistance poses a major challenge for its clinical application. Recent studies have shown that quercetin, a natural flavonoid found in various plants and foo...
Autores principales: | Li, Xin, Guo, Shu, Xiong, Xi-Kun, Peng, Bao-Ying, Huang, Jun-Ming, Chen, Mei-Fen, Wang, Feng-Yan, Wang, Jian-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746132/ https://www.ncbi.nlm.nih.gov/pubmed/31528215 http://dx.doi.org/10.7150/jca.31045 |
Ejemplares similares
-
Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression
por: Paschall, Amy V, et al.
Publicado: (2014) -
XIAP and cIAP1 amplifications induce Beclin 1-dependent autophagy through NFκB activation
por: Lin, Fang, et al.
Publicado: (2015) -
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
por: Vashisht, Monika, et al.
Publicado: (2023) -
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium
por: Dharmapatni, Anak ASSK, et al.
Publicado: (2009) -
Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation
por: Gill, Catherine, et al.
Publicado: (2009)